Physician profile
Ryan P Dumas
NPI 1427342922
$78,302.38
in general payments reported to CMS, 2019-2025
6 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2021: $45.49 · 2022: $177 · 2023: $9,925 · 2024: $28K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $14K · Travel and Lodging: $7,025 · Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,225.00 |
| Consulting Fee | $14,000.00 |
| Travel and Lodging | $7,025.21 |
| Food and Beverage | $972.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $77,223.02 | 2023-2025 | Arrow, Quikclot, Quikclot |
| Integra Lifesciences Corporation | $399.91 | 2019 | |
| Tei Biosciences INC | $339.70 | 2019 | |
| Prytime Medical Devices, INC. | $177.16 | 2022 | |
| Acell, INC. | $117.10 | 2019 | |
| Abbott Laboratories | $45.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dumas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.